Gerresheimer AG buy papaver
Summary
This prediction ended on 12.04.12 with a price of €35.36. With a performance of 6.38%, the BUY prediction by papaver for Gerresheimer AG closed with a slight gain. papaver has 50% into this predictionGerresheimer is a German-based company that specializes in the production of high-quality glass and plastic packaging solutions for the healthcare industry. The company's products are used to store and transport medicines, vaccinations, and other healthcare products. With a global footprint, Gerresheimer operates in Europe, North America, South America, and Asia, serving leading pharmaceutical and life science companies. The company is publicly traded on the Frankfurt Stock Exchange and has a strong reputation for innovation, quality, and sustainability.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gerresheimer AG | -18.196% | -18.196% | -20.912% | -3.038% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by papaver for this prediction
In the thread Gerresheimer AG diskutieren
Gerresheimer mit stabilem Wachstum
Gerresheimer hat mit seiner Jahresprognose die Anleger verschreckt. Dabei ist das Unternehmen für seine konservativen Jahresausblicke bekannt.
Das Unternehmen rechnet mit einem stabilen Geschäft mit der Kosmetik und Pharmaindustrie und rechnet mit einem Wachstum von 5%. das ist natürlich in Zeiten in denenn die Anelger 20% und merh erwarten wenig.
Außerdem gibt es Übernahmespekulationen für das Unternehmen.